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CME: Immunology
Immunology underlies most of the biological and clinical disciplines 
in medicine. This includes autoimmune diseases, infectious diseases 
and HIV, primary immunodeficiency, cancer and transplantation 
medicine. Indeed, the formalised use of immunology knowledge, 
laboratory techniques and targeted immunotherapies in routine 
clinical practice is now commonplace in much of the world. It is 
the most rapidly advancing field, and generalists need to keep up 
with advances in knowledge that impact on patient management. 
This is the impetus behind this month’s CME, entitled ‘Updates in 
immunology and allergy’. The medical community, both clinical and 
pathology disciplines, can no longer afford to see immunology as a 
‘black box’ discipline irrelevant to day-to-day patient management 
or only applicable to the uncommon case of immunodeficiency or 
autoimmune disease. For  South African (SA) doctors this means 
considering immunology beyond HIV medicine. Is it time for 
immunology in SA, amid competing public health needs, to be 
established as a distinct specialty or sub-specialty? This issue of CME 
provides an overview and an update on clinical immunology that will 
be indispensable to all practitioners.
‘… may we live in a world without lawyers 
and court cases’ (Confucius)
A year ago, I wrote an editorial[1] lamenting the current SA penchant for 
suing health practitioners, sometimes clearly justified and warranted, but 
often as a means to easy enrichment. I predicted that patients would be 
the losers.[2] This issue of SAMJ carries much that confirms this sentiment.
Howarth et al.[3] ask whether the public is unknowingly sleep-
walking into a dystopian future. In the face of escalating costs of 
liability cover for specialists offering obstetric and neonatal care, 
spinal surgery and neurosurgery, they predict fewer doctors in these 
high-risk fields, with those remaining practising defensive medicine; 
an absence or severe curtailing of private specialist obstetric care; 
paediatricians and ophthalmologists reluctant to manage neonates; 
and fewer neurosurgeons in private practice, all restricted to the larger 
urban areas.  Patients would have to be treated in already busy state 
facilities and would have to compete for resources. Any medicolegal 
liabilities would move across to the state sector hospitals and staff.
As Howarth et al. emphatically state, the medical profession cannot 
be expected to resolve the situation, as there is no medical answer. 
Rather, private patients, private providers, public patients, public 
providers, politicians and policy pundits all have a vested interest in 
resolving the problem – the issue has to enter the public debate.
Smith et al.[4] point out that the annual premium for neurosurgeons 
in 2013 was R250 900, second only to that of obstetricians (R254 230), 
this rise having paralleled the increase in the number and amount of 
awards in malpractice litigation. (SA’s highest-ever medical damages 
settlement of R25 million was awarded in June 2013, to a patient who 
had undergone neurosurgery). Neurosurgeons are indicating that they 
would not have chosen the specialty had they envisaged the current 
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medical liability situation. A third of their 
number have discontinued performing high-
risk procedures because of the associated 
liability risk.
Walters[5] suggests mediation as an 
alternative to litigation in medical malpractice, 
and states the obvious – that healthcare would 
be much better off if the money spent on the 
legal process were rather channelled into the 
healthcare system itself. This realisation has 
led to pursuit of alternative dispute resolution 
through arbitration or mediation. Walters 
believes that mediation is perhaps the most 
effective, since the majority of complaints 
against healthcare workers or institutions 
arise out of miscommunication. Such issues 
are ideal for the mediation process, involving 
the two parties, complainant and respondent, 
communicating through a facilitator. The 
complainant or aggrieved party defines 
and addresses his or her complaint to the 
respondent; the respondent then has the 
opportunity to explain the events that led to 
the complaint or grievance. A trained mediator 
guides both parties to a point of mutual 
agreement or acceptance.
Looking at the implications of Venter v 
Roche Products (Pty) Limited and Others 
for research ethics committees, Strode and 
Singh[6] address what type of compensation 
research participants would be entitled to 
in a clinical trial when they have signed an 
informed consent document excluding certain 
forms of compensation. In this recent case, the 
court considered whether the plaintiff was 
entitled to claim for non-medical costs (pain 
and suffering, loss of income and general 
damages). His application for damages was 
dismissed because he had voluntarily agreed 
to the limited compensation as set out in 
the informed consent form, which had been 
approved by both the local research ethics 
committees and the Medicines Control 
Council.
The article warns that research ethics 
committees have the obligation both to ensure 
that compensation clauses in informed-
consent documents are carefully reviewed 
and that these are made clear to potential 
research participants.
Asking ‘Who will guard the guards?’, Parrish 
and Blockman[7] aim to raise awareness of 
conflict of interest (COI) issues, including some 
tactics used by the pharmaceutical industry to 
influence thought leaders. COI exists when 
professional judgement in a primary interest 
is unduly influenced by a secondary interest 
and fosters a conflict in loyalties that translates 
into a biased decision, with the potential 
for harm. A good practical example is that, 
in the wake of reports regarding the risk of 
myocardial infarction in diabetics treated with 
rosiglitazone, authors who had favourable 
views on the safety of rosiglitazone were three 
times more likely to have a financial conflict of 
interest with a pharmaceutical company than 
were authors who had unfavourable views.[8]
The Ebola epidemic 
rages on …
As the Ebola epidemic rages,[9,10] clinicians 
should ask every febrile patient: ‘Which African 
country(ies) have you recently visited?’ We are 
also reminded that the occupational risk of 
infection by blood-borne viruses (BBVs) in 
healthcare practitioners (HCPs) and students 
is significant, especially in the developing 
world.[11] Three viral pathogens are known to 
pose the most serious risk: HIV, hepatitis B 
virus (HBV) and hepatitis C virus (HCV). The 
route of transmission can be percutaneous or 
mucosal, and is related to the work environment 
and practices of HCPs. Not only are HCPs at 
risk of acquiring these infections, but they also 
pose a risk to patients once infected. Rossouw 
et al.[11] offer these recommendations: all HCPs 
and all healthcare students should know their 
infection and immune status (as appropriate) 
for all three major BBVs, and all who are not 
infected with HBV should be vaccinated and 
have their immune status confirmed prior to 
initiation of training.
Appropriateness of CT 
and MRI scans
Computed tomography (CT) and magnetic 
resonance imaging (MRI) are now an essential 
part of modern healthcare, enabling the 
practitioner to make non-invasive diagnoses. 
Imaging is one of the fastest-growing services 
in medicine, amounting to $100 000 billion 
annually in the USA. The clinical information 
obtained, and their increased accessibility, 
has made these modalities attractive to both 
patients and referring physicians. However, 
marked increases in imaging utilisation are 
now straining healthcare expenditure and 
threatening health system sustainability.
Becker et al.[12] question the appropriateness 
of CT and MRI scans in the Eden and Central 
Karoo districts of the Western Cape. The 
increased utilisation of diagnostic imaging (see 
Fig. 2 of the article, reproduced below) has 
brought with it significant economic risks, 
plus medical risks through increased radiation 
exposure, with its accompanying carcinogenic 
potential, and the unforeseen gadolinium-
related nephrogenic systemic fibrosis, over 
and above the well-known mild allergies and 
anaphylactoid responses.
The recommendation is that consultants be 
required to grant permission for CT or MRI, 
as at George Hospital, but with awareness 
of the American College of Radiologists 
Appropriateness Criteria and and the Royal 
College of Radiology Guidelines. 
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Fig. 2. CT and MRI scans done in the Eden and Central Karoo districts of the Western Cape Province, 
SA, from April 2011 to November 2013. (CT = computed tomography; MRI = magnetic resonance 
imaging; SA = South Africa.)
